Li-li Zheng

Molecular Biology · 2023

A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Li-li Zheng trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain
  2. N. Vargesson
  3. Peter Carmeliet

Papers from Li-li Zheng's perspective

Ordered by how strongly the researchers Li-li Zheng trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  2. Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis (Cancer Cell)
  3. Molecular mechanisms and clinical applications of angiogenesis (Nature)
  4. Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
  5. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
  6. Basic and therapeutic aspects of angiogenesis. (Cell)
  7. Opinion: Angiogenesis: an organizing principle for drug discovery? (Nature reviews. Drug discovery)
  8. New functions for the matrix metalloproteinases in cancer progression (Nature Reviews. Cancer)
  9. Sorafenib in advanced clear-cell renal-cell carcinoma. (New England Journal of Medicine)
  10. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis (Cancer Research)

Their papers